Research Article

Establishment and Validation for Predicting the Lymph Node Metastasis in Early Gastric Adenocarcinoma

Table 2

Difference analysis of patients with or without LNM in the training set.

VariablesTotal (n = 505)Non-LNM (n = 398)LNM (n = 107)Statistic

Age (years), mean ± SD69.05 ± 11.7669.41 ± 11.6267.74 ± 12.24t = 1.300.193
Gender, n (%)χ2 = 0.2660.606
 Female214 (42.38)171 (42.96)43 (40.19)
 Male291 (57.62)227 (57.04)64 (59.81)
T stage, n (%)χ2 = 30.817<0.001
 T1a176 (34.85)163 (40.95)13 (12.15)
 T1b329 (65.15)235 (59.05)94 (87.85)
Primary site, n (%)χ2 = 0.4500.930
 Overlap41 (8.12)31 (7.79)10 (9.35)
 Lower267 (52.87)210 (52.76)57 (53.27)
 Middle185 (36.63)147 (36.93)38 (35.51)
 Upper12 (2.38)10 (2.51)2 (1.87)
Type, n (%)χ2 = 2.0760.354
 Diffuse36 (7.13)26 (6.53)10 (9.35)
 Intestinal424 (83.96)339 (85.18)85 (79.44)
 Others45 (8.91)33 (8.29)12 (11.21)
Tumor size (cm), n (%)χ2 = 27.052<0.001
 <1135 (26.73)110 (27.64)25 (23.36)
 1-117 (23.17)92 (23.12)25 (23.36)
 2-60 (11.88)43 (10.80)17 (15.89)
 3-101 (20.00)66 (16.58)35 (32.71)
 4-92 (18.22)87 (21.86)5 (4.67)
Grade, n (%)χ2 = 15.375<0.001
 I78 (15.45)72 (18.09)6 (5.61)
 II206 (40.79)167 (41.96)39 (36.45)
 III221 (43.76)159 (39.95)62 (57.94)

Note: LNM: lymph node metastasis.